BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 19936703)

  • 1. Reduced plasma levels of glucagon-like peptide-1 in elderly men are associated with impaired glucose tolerance but not with coronary heart disease.
    Nathanson D; Zethelius B; Berne C; Holst JJ; Sjöholm A; Nyström T
    Diabetologia; 2010 Feb; 53(2):277-80. PubMed ID: 19936703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma level of glucagon-like peptide 1 in obese Egyptians with normal and impaired glucose tolerance.
    Hussein MS; Abushady MM; Refaat S; Ibrahim R
    Arch Med Res; 2014 Jan; 45(1):58-62. PubMed ID: 24321596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered Plasma Levels of Glucagon, GLP-1 and Glicentin During OGTT in Adolescents With Obesity and Type 2 Diabetes.
    Manell H; Staaf J; Manukyan L; Kristinsson H; Cen J; Stenlid R; Ciba I; Forslund A; Bergsten P
    J Clin Endocrinol Metab; 2016 Mar; 101(3):1181-9. PubMed ID: 26745255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action.
    Faerch K; Vaag A; Holst JJ; Glümer C; Pedersen O; Borch-Johnsen K
    Diabetologia; 2008 May; 51(5):853-61. PubMed ID: 18317726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired secretion of glucagon-like peptide 1 during oral glucose tolerance test in patients with newly diagnosed type 2 diabetes mellitus.
    Wang XL; Ye F; Li J; Zhu LY; Feng G; Chang XY; Sun K
    Saudi Med J; 2016 Jan; 37(1):48-54. PubMed ID: 26739974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired secretion of total glucagon-like peptide-1 in people with impaired fasting glucose combined impaired glucose tolerance.
    Zhang F; Tang X; Cao H; Lü Q; Li N; Liu Y; Zhang X; Zhang Y; Cao M; Wan J; An Z; Tong N
    Int J Med Sci; 2012; 9(7):574-81. PubMed ID: 22991496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study.
    Laakso M; Zilinskaite J; Hansen T; Boesgaard TW; Vänttinen M; Stancáková A; Jansson PA; Pellmé F; Holst JJ; Kuulasmaa T; Hribal ML; Sesti G; Stefan N; Fritsche A; Häring H; Pedersen O; Smith U;
    Diabetologia; 2008 Mar; 51(3):502-11. PubMed ID: 18080106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of incretin on early-phase insulin secretion and glucose excursion.
    Shen J; Chen Z; Chen C; Zhu X; Han Y
    Endocrine; 2013 Oct; 44(2):403-10. PubMed ID: 23283820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Protein/Lipid Preload Attenuates Glucose-Induced Endothelial Dysfunction in Individuals with Abnormal Glucose Tolerance.
    Tricò D; Nesti L; Frascerra S; Baldi S; Mengozzi A; Natali A
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32664350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of insulin release and insulin sensitivity through oral glucose tolerance test: differences between NGT, IFG, IGT, and type 2 diabetes mellitus. A cross-sectional and follow-up study.
    Pontiroli AE; Pizzocri P; Caumo A; Perseghin G; Luzi L
    Acta Diabetol; 2004 Jun; 41(2):70-6. PubMed ID: 15224208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Older Subjects With β-Cell Dysfunction Have an Accentuated Incretin Release.
    de Jesús Garduno-Garcia J; Gastaldelli A; DeFronzo RA; Lertwattanarak R; Holst JJ; Musi N
    J Clin Endocrinol Metab; 2018 Jul; 103(7):2613-2619. PubMed ID: 29672742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The GLP-1 response to glucose does not mediate beta and alpha cell dysfunction in Hispanics with abnormal glucose metabolism.
    Adams E; Genter P; Keefe E; Sandow K; Gray V; Rotter JI; Chen YI; Ipp E
    Diabetes Res Clin Pract; 2018 Jan; 135():185-191. PubMed ID: 29155153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of beta-cell dysfunction of impaired glucose tolerance: evidence for impairment of incretin-induced insulin secretion.
    Fritsche A; Stefan N; Hardt E; Häring H; Stumvoll M
    Diabetologia; 2000 Jul; 43(7):852-8. PubMed ID: 10952457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between plasma GIP and GLP-1 levels in individuals with normal and impaired glucose tolerance.
    Marathe CS; Pham H; Marathe JA; Trahair LG; Huynh L; Wu T; Phillips LK; Rayner CK; Nauck MA; Horowitz M; Jones KL
    Acta Diabetol; 2020 May; 57(5):583-587. PubMed ID: 31848710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo insulin sensitivity and secretion in obese youth: what are the differences between normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes?
    Bacha F; Gungor N; Lee S; Arslanian SA
    Diabetes Care; 2009 Jan; 32(1):100-5. PubMed ID: 18835946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study.
    Kabootari M; Hasheminia M; Azizi F; Mirbolouk M; Hadaegh F
    Cardiovasc Diabetol; 2020 Mar; 19(1):41. PubMed ID: 32228577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal secretion of the incretin hormones glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 during gestational diabetes mellitus.
    Cypryk K; Vilsbøll T; Nadel I; Smyczyńska J; Holst JJ; Lewiński A
    Gynecol Endocrinol; 2007 Jan; 23(1):58-62. PubMed ID: 17484514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance.
    Rask E; Olsson T; Söderberg S; Holst Jj Jj; Tura A; Pacini G; Ahrén B
    Metabolism; 2004 May; 53(5):624-31. PubMed ID: 15131768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-like peptide 1 increases secretory burst mass of pulsatile insulin secretion in patients with type 2 diabetes and impaired glucose tolerance.
    Ritzel R; Schulte M; Pørksen N; Nauck MS; Holst JJ; Juhl C; März W; Schmitz O; Schmiegel WH; Nauck MA
    Diabetes; 2001 Apr; 50(4):776-84. PubMed ID: 11289042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired glucose tolerance (IGT) is associated with reduced insulin-induced suppression of glucagon concentrations.
    Ahrén B; Larsson H
    Diabetologia; 2001 Nov; 44(11):1998-2003. PubMed ID: 11719830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.